|
1.
|
|
14 p, 856.8 KB |
/
Roncero, Carlos (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Szerman, Néstor (Hospital General Universitario Gregorio Marañón) ;
Terán, Antonio (Outpatient Drug Clinic, Hospital San Juan de Dios, Palencia, Spain) ;
Pino, Carlos (Pontevedra City Council Drug Dependence Service, Galician Health Service (Xunta de Galicia), Pontevedra, Spain) ;
Vázquez, José María (Outpatient Drug Clinic Sants, Barcelona Public Health Agency (ASPB), Barcelona, Spain) ;
Velasco, Elena (Medical Affairs Department, Janssen-Cilag S.A., Madrid, Spain) ;
García-Dorado, Marta (Medical Affairs Department, Janssen-Cilag S.A., Madrid, Spain) ;
Casas, Miguel (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
There is a need to evaluate the professionals' perception about the consequences of the lack of therapeutic adherence in the evolution of patients with co-occurring disorders. An online survey, released on the Socidrogalcohol [Spanish Scientific Society for Research on Alcohol, Alcoholism and other Drug Addictions] and Sociedad Española de Patología Dual [the Spanish Society of Dual Pathology] web pages, was answered by 250 professionals who work in different types of Spanish health centers where dual diagnosis patients are assisted. [...]
2016 -  10.2147/PPA.S108678
Patient preference and adherence, Vol. 10 (september 2016) , p. 1855-1868
|
|
4.
|
|
20 p, 358.8 KB |
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients : Results from an international multi-center study exploring DSM-IV and DSM-5 criteria
/
van de Glind, Geurt (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ;
Konstenius, Maija (Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden) ;
Koeter, Maarten W.J. (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ;
van Emmerik-van Oortmerssen, Katelijne (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Carpentier, Pieter-Jan (Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands) ;
Kaye, Sharlene (National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia) ;
Degenhardt, Louisa (Melbourne School of Population and Global Health, University of Melbourne, Australia) ;
Skutle, Arvid (Bergen Clinics Foundation, Bergen, Norway) ;
Franck, Johan (Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden) ;
Bu, Eli-Torild (Bergen Clinics Foundation, Bergen, Norway) ;
Moggi, Franz (University Hospital of Psychiatry Bern and Department of Psychology, University of Fribourg, Fribourg, Switzerland) ;
Dom, Geert (Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium) ;
Verspreet, Sofie (Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium) ;
Demetrovics, Zsolt (Institute of Psychology, Eötvös Loránd University, Budapest, Hungary) ;
Kapitány-Fövény, Máté (Nyíro Gyula Hospital Drug Outpatient and Prevention Center, Budapest, Hungary) ;
Fatséas, Melina (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ;
Auriacombe, Marc (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ;
Schillinger, Arild (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ;
Møller, Merete (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ;
Johnson, Brian (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Faraone, Stephen V. (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Ramos-Quiroga, J. Antoni (Hospital Universitari Vall d'Hebron) ;
Casas, Miguel (Hospital Universitari Vall d'Hebron) ;
Allsop, Steve (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Carruthers, Susan (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Schoevers, Robert A. (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Wallhed, Sara (Stockholm Centre for Dependency Disorders, Sweden) ;
Barta, Csaba (Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary) ;
Alleman, Peter (Alcohol Treatment Research, Kirchlindach and Ellikon, Switzerland) ;
Levin, Frances R. (Columbia University/New York State Psychiatric Institute, New York City, NY, USA) ;
van den Brink, Wim (Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) ;
Universitat Autònoma de Barcelona
Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) in substance use disorder (SUD) patients, ranging from 2 to 83%. A better understanding of the possible reasons for this variability and the effect of the change from DSM-IV to DSM-5 is needed. [...]
2013 - 10.1016/j.drugalcdep.2013.09.026
Drug and alcohol dependence, Vol. 134 (october 2013) , p. 158-166
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
